Skip to main content

#151841

Anti-NSun2 [EF-1]

Cat. #151841

Anti-NSun2 [EF-1]

Cat. #: 151841

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 10-12 weeks

Target: NSun2 (Misu)

Class: Polyclonal

Application: IF ; IP ; WB

Reactivity: Human

Host: Rabbit

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Michaela Frye ; Fiona Watt

Institute: Cancer Research UK, London Research Institute: Lincoln's Inn Fields

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-NSun2 [EF-1]
  • Cancer: Breast cancer
  • Cancers detailed: Breast cancer
  • Research fields: Genetics
  • Clone: EF-1
  • Tool sub type: Primary antibody
  • Class: Polyclonal
  • Conjugation: Unconjugated
  • Molecular weight: 80 kDa
  • Reactivity: Human
  • Host: Rabbit
  • Application: IF ; IP ; WB
  • Description: NSun2 is a cytosine-5 RNA methyltransferase of transfer RNAs (tRNAs) and other non-coding RNAs. NSun2 is expressed in various tissues, including skin, brain and testis. Expression of Nsun2 is up-regulated in many tumours.
  • Immunogen: NSun2 (Misu) peptides conjugated with keyhole limpet hemocyanin
  • Immunogen uniprot id: N/A
  • Recommended controls: Human keratinocytes, human breast cancer cell lines

Target Details

  • Target: NSun2 (Misu)
  • Molecular weight: 80 kDa
  • Tissue cell line specificity: Human keratinocytes, human breast cancer cell lines
  • Target background: NSun2 is a cytosine-5 RNA methyltransferase of transfer RNAs (tRNAs) and other non-coding RNAs. NSun2 is expressed in various tissues, including skin, brain and testis. Expression of Nsun2 is up-regulated in many tumours.

Applications

  • Application: IF ; IP ; WB

Handling

  • Format: Liquid
  • Concentration: 0.9-1.1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: Whole serum
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Dry ice

References

  • Frye et al. 2010. Cancer Lett. 289(1):71-80. PMID: 19740597.
  • Genomic gain of 5p15 leads to over-expression of Misu (NSUN2) in breast cancer.
  • Hussain et al. 2009. J Cell Biol. 186(1):27-40. PMID: 19596847.
  • The nucleolar RNA methyltransferase Misu (NSun2) is required for mitotic spindle stability.
  • Frye et al. 2006. Curr Biol. 16(10):971-81. PMID: 16713953.
  • The RNA methyltransferase Misu (NSun2) mediates Myc-induced proliferation and is upregulated in tumors.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.